Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | CDC14B | O60729 | 3/20 | 0.33 |
| ▸ | CDC14A | Q9UNH5 | 3/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 2/20 | 0.32 |
| ▸ | PPARG | P37231 | 2/20 | 0.32 |
| ▸ | PPARA | Q07869 | 2/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22845313 | 0.90 | CDC14B (0.32) | ADRB2CDC14BCDC14AMAOAL3MBTL1 | |
| SCHEMBL21756018 | 0.89 | ALOX5 (0.34) | ADRB2CDC14BCDC14AALOX5MAOA | |
| SCHEMBL23692624 | 0.88 | PPARG (0.35) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL25717487 | 0.88 | PPARG (0.33) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL27451757 | 0.88 | WEE1 (0.33) | ALOX5HSP90AA1HSP90AB1 | |
| SCHEMBL27451690 | 0.87 | WEE1 (0.34) | CDC14BCDC14AHSP90AA1HSP90AB1 | |
| SCHEMBL24030726 | 0.87 | MAPT (0.33) | ADRB2CYP2C9CYP2C19 | |
| SCHEMBL24633097 | 0.87 | ALOX5 (0.48) | CDC14BCDC14AALOX5MAOAPPARG | |
| SCHEMBL23690824 | 0.86 | PPARG (0.34) | ALOX5PPARGPPARACYP2C9CYP2C19 | |
| SCHEMBL24065324 | 0.84 | ALDH1A1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210184137-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2021-06-17 | — | — | US | disclosed |
| WO-2020022769-A1 | A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2020-01-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210184137-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | SOD1, L1CAM, ACHE | ADRB2 4527/4885CDC14B 2254/4885CDC14A 2221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.